Aktuellt
SENASTE
Redeye saw a sales development roughly in line with what was expected. Costs were a bit lower than expected in the quarter, where operating costs improved. Paxman is still showing impressive growth, with a 24% increase in the quarter. Cost control compensates for slightly lower sales than expected. The quarters can be volatile. However, with a solid performance, our confidence in the case remains, and there is a long runway of potential growth ahead.
LÄS MER
